• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD NEXIVA 20 GA X 1.25IN SP WITH MAXZERO; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD NEXIVA 20 GA X 1.25IN SP WITH MAXZERO; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Catalog Number 383557
Device Problems Defective Device (2588); Insufficient Information (3190)
Patient Problems Hemolysis (1886); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/28/2024
Event Type  malfunction  
Manufacturer Narrative
H.3.If a device evaluation and/or device history review is completed, a supplemental report will be filed.
 
Event Description
It was reported that bd nexiva 20 ga x 1.25in sp with maxzero hemolysis the following information was provided by the initial reporter: since december/january 2023-2024 uz gent has been using the nexiva catheters as a result of backorders of their regular catheters (autguard).They have notices an increased hemolysis level on er department every since (+/-10%).¿ was obvious after the sampling that the sample was hemolyzed? = no, we did not evaluate the sample macroscopically.Internal lab criteria classify a sample as hemolyzed when the h-index measured on architect c16000 is >100.By evaluating our hemolysis index a the emergency department, we observed that the number of samples with a h-index >100 increased from 6-7% to 9.5-10% ¿ was there any delay in treatment? = this can not be deduced from the obtained data.¿ any negative consequences for the patient? = this can not be deduced from the obtained data.
 
Event Description
We have this issue with all the nexvia catheters that we use at the emergency department, which is lotnumber independent.
 
Manufacturer Narrative
As no physical sample, picture sample, or lot number was provided for evaluation by our quality engineer team, a complete investigation could not be performed.There are current quality controls in place to detect this type of product malfunction during the production process.Based on the limited investigation results, a cause for the reported incident could not be determined.Should you again experience any problems with our product we would appreciate the opportunity to conduct a thorough analysis.Examination of the product involved may provide clarification as to the cause for the reported failure.Complaints received for this device and reported condition will continue to be tracked and trended.Our quality team regularly reviews the collected data for identification of emerging trends.
 
Manufacturer Narrative
As no physical sample, picture sample, or lot number was provided for evaluation by our quality engineer team, a complete investigation could not be performed.There are current quality controls in place to detect this type of product malfunction during the production process.Based on the limited investigation results, a cause for the reported incident could not be determined.Should you again experience any problems with our product we would appreciate the opportunity to conduct a thorough analysis.Examination of the product involved may provide clarification as to the cause for the reported failure.Complaints received for this device and reported condition will continue to be tracked and trended.Our quality team regularly reviews the collected data for identification of emerging trends.
 
Event Description
No additional information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD NEXIVA 20 GA X 1.25IN SP WITH MAXZERO
Type of Device
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MX 
Manufacturer (Section G)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MX  
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key19011678
MDR Text Key339126148
Report Number9610847-2024-00073
Device Sequence Number1
Product Code FPA
UDI-Device Identifier30382903835578
UDI-Public(01)30382903835578
Combination Product (y/n)N
Reporter Country CodeBE
PMA/PMN Number
K170336
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 04/25/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/01/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number383557
Device Lot NumberUNKNOWN
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/25/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
-
-